ARK Genomic Revolution ETF Rating → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free ARKG Stock Alerts $24.90 -0.19 (-0.76%) (As of 05/10/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings ARK Genomic Revolution ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy2.63Holdings in ARKG have an aggregate rating of Moderate Buy based on 394 analyst ratings issued in the past year covering 38 companies (99.3% of the portfolio).ARKG Aggregate Price Target$46.1685.38% UpsideHigh Prediction$67.63Average Prediction$46.16Low Prediction$27.51Holdings in ARKG have an aggregate price target of $46.16 and a range of $27.51 to $67.63 covering 38 companies (99.3% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 ARKG Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.04%CRSPCRISPR Therapeutics$51.17-4.4%3 of 5 stars2.35$73.93 44.5%17Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage6.78%TWSTTwist Bioscience$42.37-1.9%2 of 5 stars3.00$42.50 0.3%6Insider Selling5.49%RXRXRecursion Pharmaceuticals$8.60-0.5%2 of 5 stars2.40$12.75 48.3%5Earnings ReportAnalyst ForecastNews Coverage5.27%EXASExact Sciences$53.51-1.2%5 of 5 stars2.92$95.40 78.3%13Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume4.69%SDGRSchrödinger$22.73-1.8%3 of 5 stars2.67$42.80 88.3%94.41%IONSIonis Pharmaceuticals$39.08-1.0%4 of 5 stars2.71$59.54 52.4%14Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓Gap Down3.93%NTLAIntellia Therapeutics$24.46-1.6%4 of 5 stars2.69$66.77 173.0%13Analyst ForecastNews Coverage3.81%TXG10x Genomics$25.99-1.5%5 of 5 stars2.58$48.50 86.6%12Gap Down3.60%DNAGinkgo Bioworks$0.76-17.4%2 of 5 stars1.80$2.20 189.1%5Earnings ReportAnalyst DowngradeShort Interest ↑News CoverageGap DownHigh Trading Volume3.48%BEAMBeam Therapeutics$21.26-5.7%1 of 5 stars2.38$40.18 89.0%13Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage3.47%CDNACareDx$14.83+34.1%2 of 5 stars2.75$14.00 -5.6%4Analyst ForecastShort Interest ↑News CoverageGap UpHigh Trading Volume3.44%ARCTArcturus Therapeutics$27.26+1.8%2 of 5 stars3.00$61.33 125.0%7Analyst ForecastShort Interest ↑News Coverage3.31%TDOCTeladoc Health$11.95-2.4%3 of 5 stars2.35$18.73 56.8%173.29%MRNAModerna$117.31-4.4%3 of 5 stars2.25$126.89 8.2%16Analyst ForecastInsider Selling3.27%ACCDAccolade$7.21-1.1%4 of 5 stars2.76$14.14 96.2%17Analyst ForecastShort Interest ↑2.94%VCYTVeracyte$21.37+3.6%3 of 5 stars2.60$27.50 28.7%5Earnings ReportAnalyst ForecastShort Interest ↑Gap Down2.83%VEEVVeeva Systems$203.78-0.1%5 of 5 stars2.65$234.90 15.3%20Short Interest ↓2.66%VRTXVertex Pharmaceuticals$422.78+0.9%4 of 5 stars2.48$432.18 2.2%25Earnings ReportAnalyst Forecast2.47%LABStandard BioTools$2.40-0.4%2 of 5 stars3.00$3.58 49.3%32.42%NRIXNurix Therapeutics$13.51-3.2%3 of 5 stars2.83$21.33 57.9%62.11%ADPTAdaptive Biotechnologies$3.50-1.7%4 of 5 stars2.67$6.80 94.3%6Earnings ReportShort Interest ↑1.76%MASS908 Devices$5.70-1.0%3 of 5 stars3.00$14.00 145.6%1Short Interest ↑News CoverageHigh Trading Volume1.63%INCYIncyte$53.06-0.8%5 of 5 stars2.47$74.93 41.2%17Short Interest ↑1.57%QSIQuantum-Si$1.70-7.1%2 of 5 stars2.33$2.67 56.9%3Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.53%PACBPacific Biosciences of California$1.77+2.9%3 of 5 stars2.53$7.68 334.0%15Earnings ReportAnalyst ForecastNews Coverage1.41%CMPSCOMPASS Pathways$7.86-8.0%1 of 5 stars3.00$47.40 503.1%5Gap Up1.39%VERVVerve Therapeutics$6.01-5.5%3 of 5 stars2.75$33.00 449.1%8Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.21%REGNRegeneron Pharmaceuticals$973.80+0.6%4 of 5 stars2.70$981.71 0.8%20Positive News1.19%ABSIAbsci$4.91-4.5%3 of 5 stars3.00$9.25 88.4%4Upcoming EarningsShort Interest ↓Positive News1.14%PRMEPrime Medicine$5.61-1.9%4 of 5 stars2.73$16.70 197.7%11Analyst ForecastNews Coverage1.12%PATHUiPath$19.22-0.9%4 of 5 stars2.50$27.41 42.6%18Insider Selling1.08%AMGNAmgen$310.15-0.9%5 of 5 stars2.52$305.65 -1.5%21Analyst Forecast1.05%CERSCerus$1.73-9.4%3 of 5 stars2.67$3.83 121.6%3Positive News0.73%PSNLPersonalis$1.57-4.8%4 of 5 stars3.00$5.00 218.5%3Analyst ForecastAnalyst RevisionNews Coverage0.64%RPTXRepare Therapeutics$3.50-3.8%4 of 5 stars3.00$17.33 395.2%4Upcoming EarningsNews Coverage0.59%NTRANatera$105.29+10.2%1 of 5 stars3.00$95.13 -9.6%15Earnings ReportAnalyst DowngradeInsider SellingNews CoverageGap UpHigh Trading Volume0.50%GHGuardant Health$22.37+15.1%5 of 5 stars2.83$35.78 59.9%12Short Interest ↑News CoverageHigh Trading Volume0.04%SNTISenti Biosciences$0.372 of 5 stars3.00$6.00 1,526.5%1Short Interest ↑News Coverage This page (BATS:ARKG) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmith[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
